Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


04.06.2018

3 Alzheimers Dement
2 Brain
2 Curr Alzheimer Res
1 Exp Neurol
4 J Alzheimers Dis
2 J Biol Chem
1 J Neurochem
1 Nat Neurosci
2 Neurobiol Aging
2 Neuropsychology
1 Neurosci Lett
1 Neuroscience
3 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimers Dement

  1. KHACHATURIAN AS, Hayden KM, Mielke MM, Tang Y, et al
    New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia.
    Alzheimers Dement. 2018 May 26. pii: S1552-5260(18)30155.
    PubMed     Text format    

  2. BROOKMEYER R, Abdalla N
    Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease.
    Alzheimers Dement. 2018 May 7. pii: S1552-5260(18)30098.
    PubMed     Text format     Abstract available

  3. BUCKLEY RF, Mormino EC, Amariglio RE, Properzi MJ, et al
    Sex, amyloid, and APOE epsilon4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts.
    Alzheimers Dement. 2018 May 24. pii: S1552-5260(18)30132.
    PubMed     Text format     Abstract available


    Brain

  4. TIJMS BM, Visser PJ
    Chasing the start of sporadic Alzheimer's disease running in families.
    Brain. 2018;141:1589-1591.
    PubMed     Text format    

  5. HAMPEL H, Mesulam MM, Cuello AC, Farlow MR, et al
    The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.
    Brain. 2018 May 29. pii: 5023826. doi: 10.1093.
    PubMed     Text format     Abstract available


    Curr Alzheimer Res

  6. WAN L, Lu J, Fu J, Huang J, et al
    Acetylcholinesterase inhibitor donepezil effects on plasma beta-hydroxybutyrate levels in the treatment of Alzheimer's disease.
    Curr Alzheimer Res. 2018 May 31. pii: CAR-EPUB-90849.
    PubMed     Text format     Abstract available

  7. ZVEROVA M, Kitzlerova E, Fisar Z, Jirak R, et al
    Interplay between the APOE genotype and possible plasma biomarkers in Alzheimer's disease.
    Curr Alzheimer Res. 2018 May 31. pii: CAR-EPUB-90848.
    PubMed     Text format     Abstract available


    Exp Neurol

  8. GIRALT A, de Pins B, Cifuentes-Diaz C, Lopez-Molina L, et al
    PTK2B/Pyk2 overexpression improves a mouse model of Alzheimer's disease.
    Exp Neurol. 2018 May 24. pii: S0014-4886(18)30160.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  9. ADAMS SL, Benayoun L, Tilton K, Mellott TJ, et al
    Immunohistochemical Analysis of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) Expression in the Rat and Human Hippocampus: Decline in CA3 During Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 18. pii: JAD171065. doi: 10.3233/JAD-171065.
    PubMed     Text format     Abstract available

  10. STEENLAND K, Zhao L, John SE, Goldstein FC, et al
    A 'Framingham-like' Algorithm for Predicting 4-Year Risk of Progression to Amnestic Mild Cognitive Impairment or Alzheimer's Disease Using Multidomain Information.
    J Alzheimers Dis. 2018 May 18. pii: JAD170769. doi: 10.3233/JAD-170769.
    PubMed     Text format     Abstract available

  11. SCHERR M, Pasquini L, Benson G, Nuttall R, et al
    Decoupling of Local Metabolic Activity and Functional Connectivity Links to Amyloid in Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 19. pii: JAD180022. doi: 10.3233/JAD-180022.
    PubMed     Text format     Abstract available

  12. ALOSCO ML, Sugarman MA, Besser LM, Tripodis Y, et al
    A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2018 May 19. pii: JAD180017. doi: 10.3233/JAD-180017.
    PubMed     Text format     Abstract available


    J Biol Chem

  13. SUDOM A, Talreja S, Danao J, Bragg E, et al
    Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2.
    J Biol Chem. 2018 May 24. pii: RA118.002352. doi: 10.1074/jbc.RA118.002352.
    PubMed     Text format     Abstract available

  14. BISHOF I, Dammer EB, Duong DM, Kundinger S, et al
    RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.
    J Biol Chem. 2018 May 25. pii: RA118.001747. doi: 10.1074/jbc.RA118.001747.
    PubMed     Text format     Abstract available


    J Neurochem

  15. HOPP SC, Bihlmeyer NA, Corradi JP, Vanderburg C, et al
    Neuronal calcineurin transcriptional targets parallel changes observed in Alzheimer disease brain.
    J Neurochem. 2018 May 28. doi: 10.1111/jnc.14469.
    PubMed     Text format     Abstract available


    Nat Neurosci

  16. MOSTAFAVI S, Gaiteri C, Sullivan SE, White CC, et al
    A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer's disease.
    Nat Neurosci. 2018;21:811-819.
    PubMed     Text format     Abstract available


    Neurobiol Aging

  17. KOSTER RN, Jesper R, Bente P
    The total number of myelinated nerve fibers is reduced in corpus callosum in brains from patients with Alzheimer's disease.
    Neurobiol Aging. 2018;69:58-64.
    PubMed     Text format     Abstract available

  18. ABDEL-HAFIZ L, Muller-Schiffmann A, Korth C, Fazari B, et al
    Abeta dimers induce behavioral and neurochemical deficits of relevance to early Alzheimer's disease.
    Neurobiol Aging. 2018;69:1-9.
    PubMed     Text format     Abstract available


    Neuropsychology

  19. LOBUE C, Woon FL, Rossetti HC, Hynan LS, et al
    Traumatic brain injury history and progression from mild cognitive impairment to Alzheimer disease.
    Neuropsychology. 2018;32:401-409.
    PubMed     Text format     Abstract available

  20. COGNE M, Auriacombe S, Vasa L, Tison F, et al
    Are visual cues helpful for virtual spatial navigation and spatial memory in patients with mild cognitive impairment or Alzheimer's disease?
    Neuropsychology. 2018;32:385-400.
    PubMed     Text format     Abstract available


    Neurosci Lett

  21. ZAJKOWICZ A, Gdowicz-Klosok A, Krzesniak M, Janus P, et al
    The Alzheimer's disease-associated TREM2 gene is regulated by p53 tumor suppressor protein.
    Neurosci Lett. 2018 May 26. pii: S0304-3940(18)30388.
    PubMed     Text format     Abstract available


    Neuroscience

  22. LI J, Rao D, Gibbs RB
    Effects of Cholinergic Lesions and Cholinesterase Inhibitors on Aromatase and Estrogen Receptor Expression in Different Regions of the Rat Brain.
    Neuroscience. 2018 May 28. pii: S0306-4522(18)30383.
    PubMed     Text format     Abstract available


    PLoS One

  23. MARSHALL MS, Jakubauskas B, Bogue W, Stoskute M, et al
    Analysis of age-related changes in psychosine metabolism in the human brain.
    PLoS One. 2018;13:e0193438.
    PubMed     Text format     Abstract available

  24. NYITRAI G, Spisak T, Spisak Z, Gajari D, et al
    Stepwise occlusion of the carotid arteries of the rat: MRI assessment of the effect of donepezil and hypoperfusion-induced brain atrophy and white matter microstructural changes.
    PLoS One. 2018;13:e0198265.
    PubMed     Text format     Abstract available

  25. KOBAYASHI Y, Inagawa H, Kohchi C, Kazumura K, et al
    Oral administration of Pantoea agglomerans-derived lipopolysaccharide prevents metabolic dysfunction and Alzheimer's disease-related memory loss in senescence-accelerated prone 8 (SAMP8) mice fed a high-fat diet.
    PLoS One. 2018;13:e0198493.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  26. CALLENDER JA, Yang Y, Lorden G, Stephenson NL, et al
    Protein kinase Calpha gain-of-function variant in Alzheimer's disease displays enhanced catalysis by a mechanism that evades down-regulation.
    Proc Natl Acad Sci U S A. 2018 May 29. pii: 1805046115.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: